Autopsy report · NCT05491681

AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial

“With available funding it was necessary for Sponsor to prioritize other studies. No study participants were consented or enrolled and no study sites were activated.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

BioCardia, Inc.

Sponsor type

Industry

Conditions

ARDS, Human

Interventions

intravenous delivery of allogeneic bone marrow-derived MSCs

Participants

0

Trials that died the same way

• Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)
  “No participants were enrolled, no funding obtained to perform study” (78% match in meaning)
• UCLA Couples Counseling for Combat Veterans
  “Proposed studies were not funded” (76% match in meaning)
• CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF
  “there was no funding to begin the study” (75% match in meaning)
• Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
  “No funding for the study” (75% match in meaning)
• Vasomotor Symptoms and Cardiovascular Control
  “No funding obtained to conduct study” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.